Estrogen-responsive genes TFAP2C and Myc are overexpressed in BC with poor prognosis, and lack of regulation of these genes is linked to the absence of CDKN1A resulting in anti-estrogen therapy resistance [112, 113]. This evidence concerns the gene CDKN1A and breast cancer.